In the ACTION study, 3008 individuals with obesity and 606 healthcare providers were questioned on their obesity-related perceptions, attitudes, and behaviors
For many people who've turned to online telehealth companies to find compounded obesity drugs, they say they would prefer to take the brand-name drugs, but it isn't an option for them
Call to Action If youre considering weight loss or diabetes management, dont let fear hold you back
Neither medication is superior, but 1 might work better for you than the other
Key Takeaways The global market for GLP-1 drugs could reach $190 billion by 2035, more than double 2025 levels
For Pharma: Could introduce additional competitive pressure on branded manufacturers like Novo Nordisk and Eli Lilly, encouraging continued innovation